GDP is that part of quality assurance which ensures that the quality of medicinal products are maintained throughout all stages of the supply chain from the site of manufacturer to the pharmacy or person authorized or entitled to supply medicinal products to the public, validation from 12-11-2022 to 11-11-2023.